| 2020-01-06 |
14 |
Answer to Complaint |
United States Patent Nos. 8,101,659 (the “’659
patent”), 8,796,331 (the “’331 patent”), and 8,877,938…103 mg, prior to the expiration of U.S. Patents Nos. 8,101,659 (the
Case 1:19-cv-02021-LPS Document…and every asserted claim of United States Patent No. 8,101,659 is invalid for
failing to satisfy one or… and enforceable
asserted claim of U.S. Patent No. 8,101,659.
…entered that each claim of United States Patent Nos.
8,101,659, 8,796,331, and 8,877,938 is invalid;
|
External link to document |
| 2022-08-26 |
196 |
~Util - Set Hearings AND Order |
validity of U.S. Patent Nos. 8,101,659 (the 659 patent) and 8,796,331 (the 331 patent) is scheduled for…validity of U.S. Patent Nos. 8,877,938 (the 938 patent) and 9,388,134 (the 134 patent) is scheduled for…2019
7 February 2024
1:19-cv-02021
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
| 2022-11-04 |
226 |
Stipulation-General (See Motion List for Stipulation to Extend Time) |
Order Regarding Post-Trial Briefing for U.S. Patent No. 8,796,331 by Novartis Pharmaceuticals Corporation.…2019
7 February 2024
1:19-cv-02021
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
| 2022-11-04 |
227 |
Order |
Order Regarding Post-Trial Briefing for U.S. Patent No. 8,796,331. Signed by Judge Richard G. Andrews on 11…2019
7 February 2024
1:19-cv-02021
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
| 2023-07-07 |
239 |
Opinion |
infringement
of U.S. Patent 8,877,938 (the “’938 Patent”), 9,388,134 (the “’134 Patent”), 8,101,659 (the “’659
…659
Patent”) and 8,796,331 (the “’331 Patent”). Only the ’659 Patent is at issue in this opinion.
The parties… of that patent. (/d.). I held separate trials addressing the ’938 Patent and the ’134 Patent.
(D.I. 604…Ciba-Geigy, was issued U.S.
Patent No. 5,399,578 (“the 578 Patent”). (JTX-23). That patent disclosed and claimed…the °659 Patent claims are obvious over EP ’072,
the ’996 Patent/Ksander, and the ’578 Patent/Diovan® |
External link to document |
| 2023-07-21 |
245 |
Judgment |
certain terms in the claims of U.S. Patent No. 8,101,659
(“’659 patent”) in a Memorandum Opinion and Order…
FINAL JUDGMENT Regarding U.S. Patent No. 8,101,659 (see Judgment for further details). Signed by…/VALSARTAN) ) MDL No. 20-2930-RGA
PATENT LITIGATION )
…, and to the extent that claims 1-4 of the ’659 patent
are valid, that the filing of its respective ANDA… ANDA infringed each of claims 1-4 of the ’659 patent”),
and that the products described in its respective |
External link to document |
